ASSET PURCHASE AGREEMENT By and between AstraZeneca Pharmaceuticals LP and IGI Laboratories, Inc. Dated as of September 24, 2014Asset Purchase Agreement • November 13th, 2014 • Igi Laboratories, Inc • Biological products, (no disgnostic substances) • New York
Contract Type FiledNovember 13th, 2014 Company Industry JurisdictionThis Asset Purchase Agreement (this “Agreement”) is made and executed as of September 24, 2014 (the “Effective Date”), by and between AstraZeneca Pharmaceuticals LP, a Delaware corporation (“Seller”), and IGI Laboratories, Inc., a Delaware corporation (“Buyer”). Seller and Buyer are sometimes referred to herein individually as a “Party” and collectively as the “Parties.”